US OptionsDetailed Quotes

AMGN250110C240000

Watchlist

20.15
-1.45-6.71%

15min DelayClose Jan 8 16:00 ET

20.15High20.15Low

Amgen Stock Discussion

vampirekitty169

Dec 31, 2024 09:05

🚀🚀🚀

$Amgen (AMGN.US)$ Bought as soon as I got the news and it’s +3% within 10 minutes, looking good!

What's new: Latest stock news and analysis

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 15, 2024 15:56

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...

10xStockPicks

Dec 14, 2024 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...

Mr Long Term

Dec 12, 2024 18:17

Columns These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over.

It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed.
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...

mzZephyr

Dec 3, 2024 03:57

$Amgen (AMGN.US)$ plsssss buck up!!! 🚀

Shaaaw

Nov 27, 2024 06:52

Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...

Kevin Travers

Nov 26, 2024 15:12

Columns S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today

The market again hit records Tuesday, reacting mostly positively toward incoming President-Elect Trump's comments overnight that he would put a 25% tariff on our neighbors in Canada and Mexico and 35% on Chinese goods, our three largest trading partners.
According to Census Bureau data, there are price hikes in the goods on 41% of the U.S.'s total imports; there has been $1.6T trade so far in 2024. A blanket ...

"Santa Claus Rally" in jeopardy: Can U.S. stocks get off to a good start??

Ben the Oracle

Nov 26, 2024 10:56

THIS IS NO BRAINER

$Amgen (AMGN.US)$ A 20% weight loss reduction in one year is fantastic and healthy from a medical standpoint. A 5 foot 4 inches woman at 180 pounds would loss guaranteed 36 pounds over 1 year be down to a much healthier 144 pounds. This is impressive results. I don’t understand the selloff. The human body should lose weight in a healthy fashion. I don’t know what you guys are expecting . This is great news .

PeanutButterr

Nov 26, 2024 09:55

$Amgen (AMGN.US)$ feels overdone for decent Phase 2 data.

No comment yet